VivoSim Labs at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

VivoSim Labs takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on human 3D tissue models as new approach methods for ranking risk in small molecules and antibody-drug conjugates. Its liver model grades drug-induced liver injury risk by safety margin against peak blood levels, and its intestinal model ranks gut risk in mature and dividing tissue.

OrganizationACT 2026 Attendance
vivosim.ai
Animal and in vitro model suppliers
Offers 3D human liver and intestine tissue models built from primary cells, plus liver and gastrointestinal toxicology testing services.
Poster
Mon Nov 16
5:00pm–6:30pm
Human 3D Liver NAM Enables Margin of Safety-Based DILI Risk Stratification Relative to Clinical Cmax across Small Molecules and ADCs (P419)
Nelson Exhibit Ballroom · Poster P419
New approach methods
Poster
Mon Nov 16
5:00pm–6:30pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from VivoSim Labs

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction